| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 98813-70-8 | 2-Ethynylquinoxaline | C10H6N2 |
| 98813-72-0 | 2,3-Diethynylquinoxaline | C12H6N2 |
| 98814-28-9 | 4,6-dichloro-5-methyl-2-methylsulfonyl-pyrimidine | C6H6Cl2N2O2S |
| 98815-38-4 | L-Tyrosyl-D-Alanyl-L-Phenylalanyl-D-Alanyl-L-Tyrosinamide | C33H40N6O7 |
| 98816-24-1 | 3-Chloro-5-(2-thienylsulfanyl)-1,2,4-thiadiazole | C6H3ClN2S3 |
| 98816-32-1 | N-Hydroxymethyl-3-Methylpyrazole | C5H8N2O |
| 98816-40-1 | 3-Isobutyl-1H-pyrazole | |
| 98816-60-5 | N-[4-(Diphenylphosphino)benzyl]-N-isopropyl-2-propanamine | C25H30NP |
| 98816-61-6 | N-(4-Bromobenzyl)-N-isopropyl-2-propanamine | C13H20BrN |
| 98818-34-9 | 2-Methyl-2-propanyl {(1R)-1-[(2R)-2-oxiranyl]-2-phenylethyl}carbamate | C15H21NO3 |
| 98818-35-0 | 2-Methyl-2-propanyl {(1S)-1-[(2R)-2-oxiranyl]-2-phenylethyl}carbamate | C15H21NO3 |
| 98818-36-1 | 2-Methyl-2-propanyl (1-oxo-3-phenyl-2-propanyl)carbamate | C14H19NO3 |
| 98819-09-1 | Picropolygamain | C20H16O6 |
| 98819-68-2 | ((2R,3R)-3-Phenyloxiran-2-yl)methanol | C9H10O2 |
| 98819-76-2 | Esreboxetine | C19H23NO3 |
| 98820-85-0 | 4-Methoxy-2-methylaniline | C8H11NO |
| 98822-08-3 | Furo[3,4-e][1,2]benzoxazole | C9H5NO2 |
| 98824-17-0 | 30-Hydroxy-5-(Tetrahydro-5-Methoxy-6-Methyl-2H-Pyran-2-Yl)-Semduramicin | C52H88O19 |
| 98824-26-1 | Calcitonin gene-related peptide II | |
| 98824-35-2 | N-(2-Aminoethyl)Ethane-1,2-Diamine | C4H13N3 |
| 98826-75-6 | N,N,N-Trimethyl-Methanaminium Salt With [[3-(2,2-Dicyanoethenyl)-2-Phenyl-2-Cyclohexen-1-Ylidene]Methyl]Propanedinitrile (1:1) | C24H25N5 |
| 98826-77-8 | N,N,N-Trimethyl-Methanaminium Salt With [[2-Chloro-3-(2,2-Dicyanoethenyl)-2-Cyclohexen-1-Ylidene]Methyl]Propanedinitrile (1:1) | C18H20ClN5 |
| 98826-81-4 | N,N,N-Trimethyl-Methanaminium Salt With [[3-(2,2-Dicyanoethenyl)-2-Methyl-2-Cyclohexen-1-Ylidene]Methyl]Propanedinitrile (1:1) | C19H23N5 |
| 98826-83-6 | N,N,N-Trimethyl-Methanaminium Salt With [[5-(2,2-Dicyanoethenyl)-2H-Pyran-3(6H)-Ylidene]Methyl]Propanedinitrile (1:1) | C17H19N5O |
| 98826-84-7 | 1,3,5-Heptatriene-1,1,7,7-Tetracarbonitrile, Ion(1-), N,N,N-Trimethylmethanaminium | C15H17N5 |
| 98827-44-2 | Methyl 4-hydroxy-2H-thieno[2,3-e][1,2]thiazine-3-carboxylate 1,1-dioxide | C8H7NO5S2 |
| 98827-47-5 | 2,4-Dihydro-[1,2,4]triazolo[5,4-c][1,4]benzothiazin-1-one | C9H7N3OS |
| 98827-59-9 | 3-Ethynyl-2-quinoxalinamine | C10H7N3 |
| 98829-12-0 | 2-O-Octadecylascorbic Acid | C24H44O6 |
| 98830-20-7 | 25-Hydroxydihydrotachysterol(2) | C28H46O2 |
| 98832-64-5 | Methyl 5-hydroxy-1-methyl-1H-imidazole-4-carboxylate | C6H8N2O3 |
| 98832-79-2 | Ethyl 4-methyl-3-pyridazinecarboxylate | C8H10N2O2 |
| 98832-80-5 | Ethyl 3-methyl-4-pyridazinecarboxylate | C8H10N2O2 |
| 98833-79-5 | D-Tyr-Pro-Arg-Chloromethylketone | C21H31ClN6O4 |
| 98833-92-2 | Stacofylline | C20H34ClN7O3 |
| 98834-08-3 | 4-Morpholinyl-1-Piperazinyl-Methanone | C9H17N3O2 |
| 98834-95-8 | Ethyl (2E,4E,6E)-9-formyl-10-oxo-2,4,6,8-decatetraenoate | C13H14O4 |
| 98834-97-0 | [(2E)-5,5-Dichloro-2,4-pentadien-1-ylidene]malonaldehyde | C8H6Cl2O2 |
| 98835-90-6 | Octyl 5-N,N-diethylamino-2-phenylsulfonyl-2,4-pentadienoate | C23H35NO4S |
| 98836-71-6 | alpha-((1,1'-Biphenyl)-4-Yl)-N,N,alpha-Trimethyl-1H-Imidazole-1-Ethanamine | C20H23N3 |
| 98837-51-5 | Poly(3-Butylthiophene-2,5-Diyl) | C8H10S |
| 98841-55-5 | vanadium(+2) cation formate | CHO2V |
| 98841-65-7 | N-(2-(3,4-Dimethoxyphenyl)Ethyl)-2-Nitriloethanamide | C13H16N2O3 |
| 98841-68-0 | (2,4-Dimethyl-4,5-dihydro-1,3-oxazol-4-yl)methanol | C6H11NO2 |
| 98845-64-8 | Mafosfamide-Lysine | C15H33Cl2N4O7PS2 |
| 98847-55-3 | (Hydroxymethyl)Methylcarbamic Acid 7-Chloro-2,3-Dihydro-1-Methyl-2-Oxo-5-Phenyl-1H-1,4-Benzodiazepin-3-Yl Ester | C19H18ClN3O4 |
| 98849-70-8 | 2-Nitro-5-(6-Bromohexanoylamino)Benzoic Acid | C13H15BrN2O5 |
| 98849-86-6 | Tyrosyl-Methionyl(O)-Glycyl-Ethylphenylalanine-2-Acetylhydrazide | C31H44N6O9S |
| 98849-88-8 | FLAG Peptide | C41H60N10O20 |
| 98849-99-1 | N(6)-(3-Iodo-4-Azidobenzyl)Adenosine | C17H17IN8O4 |